Human Molecular Genetics, 2003, Vol. 12, No. 8 859-867
DOI: 10.1093/hmg/ddg094
© 2003 Oxford University Press
Haplotypes extending across ACE are associated with Alzheimer's disease
1Department of Care of the Elderly, University of Bristol, The John James Building, Frenchay Hospital, Bristol, UK, 2Center for Genomics and Bioinformatics, Karolinska Institute, Stockholm, Sweden, 3Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden, 4Department of Psychology, University of Göteborg, Göteborg, Sweden, 5Department of Clinical Chemistry, Karolinska Hospital, Stockholm, Sweden, 6Department of Cardiology, Karolinska Hospital, Stockholm, Sweden, 7Department of Neuropathology, Institute of Psychiatry, King's College, London, UK and 8Department of Clinical Neuroscience and Transfusion Medicine, University of Göteborg, Sahlgren's University Hospital, Sweden
Received December 12, 2002; Accepted February 7, 2003
Numerous genes have been implicated in Alzheimer's disease (AD), but, with the exception of a demonstrated association with the 
4 allele of APOE, findings have not been consistently replicated across populations. One of the most widely studied is the gene for angiotensin I converting enzyme (ACE ). A meta-analysis of published data on a common Alu indel polymorphism in ACE was performed which indicated highly significant association of the insertion allele with AD (OR 1.30; 95% CI 1.19 – 1.41; P=4x10-8). To further explore the influence of ACE on AD, several single-nucleotide polymorphisms (SNPs) were genotyped in five independent populations represented by over 3100 individuals. Analyses based upon single markers and haplotypes revealed strong evidence of association in case – control models and also in a model examining the influence of variation in ACE upon cerebrospinal fluid levels of amyloid ß42 peptide (Aß42). The most significant evidence for association with AD was found for an SNP, A-262T, located in the ACE promoter (OR 1.64; 95% CI 1.33 –1.94; P=2x10-5). Estimates of population attributable risk for the common allele of this SNP suggest that it, or an allele in tight linkage disequilibrium (LD) with it, may contribute to as much as 35% of AD in the general population. Results support a model whereby decreased ACE activity may influence AD susceptibility by a mechanism involving ß-amyloid metabolism.
* To whom correspondence should be addressed at: Center for Genomics and Bioinformatics, Karolinska Institute, Berzeliusväg 35, 171 77 Stockholm, Sweden. Tel: +46 87286274; Fax: +46 8324826; Email: Jonathan.Prince{at}cgb.ki.se
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. W Wright and J. W Harding The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease Journal of Renin-Angiotensin-Aldosterone System, December 1, 2008; 9(4): 226 - 237. [Abstract] [PDF]
|
|
|
|
 |
|
 F.A. Sayed-Tabatabaei, B.A. Oostra, A. Isaacs, C.M. van Duijn, and J.C.M. Witteman ACE Polymorphisms Circ. Res., May 12, 2006; 98(9): 1123 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Trikalinos, G. Salanti, M. J. Khoury, and J. P. A. Ioannidis Impact of Violations and Deviations in Hardy-Weinberg Equilibrium on Postulated Gene-Disease Associations Am. J. Epidemiol., February 15, 2006; 163(4): 300 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Lehmann, M. Cortina-Borja, D. R. Warden, A. D. Smith, K. Sleegers, J. A. Prince, C. M. van Duijn, and P. G. Kehoe Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease Am. J. Epidemiol., August 15, 2005; 162(4): 305 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lei, I. N. M. Day, and I. Vorechovsky Exonization of AluYa5 in the human ACE gene requires mutations in both 3' and 5' splice sites and is facilitated by a conserved splicing enhancer Nucleic Acids Res., July 14, 2005; 33(12): 3897 - 3906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Y. Hsieh, C.-C. Chang, F.-J. Tsai, C.-M. Hsu, C.-C. Lin, and C.-H. Tsai Angiotensin I-converting enzyme ACE 2350*G and ACE-240*T-related genotypes and alleles are associated with higher susceptibility to endometriosis Mol. Hum. Reprod., January 1, 2005; 11(1): 11 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lin, L. Finn, J. Zhang, T. Young, and E. Mignot Angiotensin-converting Enzyme, Sleep-disordered Breathing, and Hypertension Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1349 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Katzov, A. M. Bennet, P. Kehoe, B. Wiman, M. Gatz, K. Blennow, B. Lenhard, N. L. Pedersen, U. de Faire, and J. A. Prince A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity Hum. Mol. Genet., November 1, 2004; 13(21): 2647 - 2657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ntais, A. Polycarpou, and J. P. A. Ioannidis Meta-Analysis of the Association of the Cathepsin D Ala224Val Gene Polymorphism with the Risk of Alzheimer's Disease: A HuGE Gene-Disease Association Review Am. J. Epidemiol., March 15, 2004; 159(6): 527 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Elkins, V. C. Douglas, and S. C. Johnston Alzheimer disease risk and genetic variation in ACE: A meta-analysis Neurology, February 10, 2004; 62(3): 363 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G Kehoe Review: The renin-angiotensin-aldosterone system and Alzheimer's disease? Journal of Renin-Angiotensin-Aldosterone System, June 1, 2003; 4(2): 80 - 93. [Abstract] [PDF]
|
|